244 related articles for article (PubMed ID: 32920733)
1. Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC).
Abdelhafez AH; Musall BC; Adrada BE; Hess K; Son JB; Hwang KP; Candelaria RP; Santiago L; Whitman GJ; Le-Petross HT; Moseley TW; Arribas E; Lane DL; Scoggins ME; Leung JWT; Mahmoud HS; White JB; Ravenberg EE; Litton JK; Valero V; Wei P; Thompson AM; Moulder SL; Pagel MD; Ma J; Yang WT; Rauch GM
Breast Cancer Res Treat; 2021 Jan; 185(1):1-12. PubMed ID: 32920733
[TBL] [Abstract][Full Text] [Related]
2. Functional Tumor Volume by Fast Dynamic Contrast-Enhanced MRI for Predicting Neoadjuvant Systemic Therapy Response in Triple-Negative Breast Cancer.
Musall BC; Abdelhafez AH; Adrada BE; Candelaria RP; Mohamed RMM; Boge M; Le-Petross H; Arribas E; Lane DL; Spak DA; Leung JWT; Hwang KP; Son JB; Elshafeey NA; Mahmoud HS; Wei P; Sun J; Zhang S; White JB; Ravenberg EE; Litton JK; Damodaran S; Thompson AM; Moulder SL; Yang WT; Pagel MD; Rauch GM; Ma J
J Magn Reson Imaging; 2021 Jul; 54(1):251-260. PubMed ID: 33586845
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Apparent Diffusion Coefficients From Peritumoral Regions as Early Predictors of Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.
Musall BC; Adrada BE; Candelaria RP; Mohamed RMM; Abdelhafez AH; Son JB; Sun J; Santiago L; Whitman GJ; Moseley TW; Scoggins ME; Mahmoud HS; White JB; Hwang KP; Elshafeey NA; Boge M; Zhang S; Litton JK; Valero V; Tripathy D; Thompson AM; Yam C; Wei P; Moulder SL; Pagel MD; Yang WT; Ma J; Rauch GM
J Magn Reson Imaging; 2022 Dec; 56(6):1901-1909. PubMed ID: 35499264
[TBL] [Abstract][Full Text] [Related]
4. Prediction of pathologic complete response to neoadjuvant systemic therapy in triple negative breast cancer using deep learning on multiparametric MRI.
Zhou Z; Adrada BE; Candelaria RP; Elshafeey NA; Boge M; Mohamed RM; Pashapoor S; Sun J; Xu Z; Panthi B; Son JB; Guirguis MS; Patel MM; Whitman GJ; Moseley TW; Scoggins ME; White JB; Litton JK; Valero V; Hunt KK; Tripathy D; Yang W; Wei P; Yam C; Pagel MD; Rauch GM; Ma J
Sci Rep; 2023 Jan; 13(1):1171. PubMed ID: 36670144
[TBL] [Abstract][Full Text] [Related]
5. A model combining pretreatment MRI radiomic features and tumor-infiltrating lymphocytes to predict response to neoadjuvant systemic therapy in triple-negative breast cancer.
Jimenez JE; Abdelhafez A; Mittendorf EA; Elshafeey N; Yung JP; Litton JK; Adrada BE; Candelaria RP; White J; Thompson AM; Huo L; Wei P; Tripathy D; Valero V; Yam C; Hazle JD; Moulder SL; Yang WT; Rauch GM
Eur J Radiol; 2022 Apr; 149():110220. PubMed ID: 35193025
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a nomogram based on pretreatment dynamic contrast-enhanced MRI for the prediction of pathologic response after neoadjuvant chemotherapy for triple-negative breast cancer.
Li Y; Chen Y; Zhao R; Ji Y; Li J; Zhang Y; Lu H
Eur Radiol; 2022 Mar; 32(3):1676-1687. PubMed ID: 34767068
[TBL] [Abstract][Full Text] [Related]
7. Is the presence of edema and necrosis on T2WI pretreatment breast MRI the key to predict pCR of triple negative breast cancer?
Harada TL; Uematsu T; Nakashima K; Sugino T; Nishimura S; Takahashi K; Hayashi T; Tadokoro Y; Watanabe J; Nakamoto S; Ito T
Eur Radiol; 2020 Jun; 30(6):3363-3370. PubMed ID: 32062698
[TBL] [Abstract][Full Text] [Related]
8. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
9. Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes.
Youk JH; Son EJ; Chung J; Kim JA; Kim EK
Eur Radiol; 2012 Aug; 22(8):1724-34. PubMed ID: 22527371
[TBL] [Abstract][Full Text] [Related]
10. MRI-Based Digital Models Forecast Patient-Specific Treatment Responses to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
Wu C; Jarrett AM; Zhou Z; Elshafeey N; Adrada BE; Candelaria RP; Mohamed RMM; Boge M; Huo L; White JB; Tripathy D; Valero V; Litton JK; Yam C; Son JB; Ma J; Rauch GM; Yankeelov TE
Cancer Res; 2022 Sep; 82(18):3394-3404. PubMed ID: 35914239
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant Systemic Therapy in Breast Cancer: Association of Contrast-enhanced MR Imaging Findings, Diffusion-weighted Imaging Findings, and Tumor Subtype with Tumor Response.
Santamaría G; Bargalló X; Fernández PL; Farrús B; Caparrós X; Velasco M
Radiology; 2017 Jun; 283(3):663-672. PubMed ID: 27875106
[TBL] [Abstract][Full Text] [Related]
12. Predictive Clinicopathologic and Dynamic Contrast-Enhanced MRI Findings for Tumor Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
Eom HJ; Cha JH; Choi WJ; Chae EY; Shin HJ; Kim HH
AJR Am J Roentgenol; 2017 Jun; 208(6):W225-W230. PubMed ID: 28350486
[TBL] [Abstract][Full Text] [Related]
13. Diffusion Tensor Imaging for Characterizing Changes in Triple-Negative Breast Cancer During Neoadjuvant Systemic Therapy.
Musall BC; Rauch DE; Mohamed RMM; Panthi B; Boge M; Candelaria RP; Chen H; Guirguis MS; Hunt KK; Huo L; Hwang KP; Korkut A; Litton JK; Moseley TW; Pashapoor S; Patel MM; Reed BJ; Scoggins ME; Son JB; Tripathy D; Valero V; Wei P; White JB; Whitman GJ; Xu Z; Yang WT; Yam C; Adrada BE; Ma J
J Magn Reson Imaging; 2024 Jan; ():. PubMed ID: 38294179
[TBL] [Abstract][Full Text] [Related]
14. Additive value of diffusion-weighted MRI in the I-SPY 2 TRIAL.
Li W; Newitt DC; Wilmes LJ; Jones EF; Arasu V; Gibbs J; La Yun B; Li E; Partridge SC; Kornak J; ; Esserman LJ; Hylton NM
J Magn Reson Imaging; 2019 Dec; 50(6):1742-1753. PubMed ID: 31026118
[TBL] [Abstract][Full Text] [Related]
15. Early ultrasound evaluation identifies excellent responders to neoadjuvant systemic therapy among patients with triple-negative breast cancer.
Adrada BE; Candelaria R; Moulder S; Thompson A; Wei P; Whitman GJ; Valero V; Litton JK; Santiago L; Scoggins ME; Moseley TW; White JB; Ravenberg EE; Yang WT; Rauch GM
Cancer; 2021 Aug; 127(16):2880-2887. PubMed ID: 33878210
[TBL] [Abstract][Full Text] [Related]
16. Evaluation with 3.0-T MR imaging: predicting the pathological response of triple-negative breast cancer treated with anthracycline and taxane neoadjuvant chemotherapy.
Kim MJ; Kim EK; Park S; Moon HJ; Kim SI; Park BW
Acta Radiol; 2015 Sep; 56(9):1069-77. PubMed ID: 25228161
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of multi-parametric breast MR imaging for predicting pathological complete response of operable breast cancer prior to neoadjuvant systemic therapy.
Tsukada H; Tsukada J; Schrading S; Strobel K; Okamoto T; Kuhl CK
Magn Reson Imaging; 2019 Oct; 62():242-248. PubMed ID: 31352016
[TBL] [Abstract][Full Text] [Related]
18. Predicting pathological complete response to neoadjuvant systemic therapy for triple-negative breast cancers using deep learning on multiparametric MRIs.
Zhou Z; Adrada BE; Candelaria RP; Elshafeey NA; Boge M; Mohamed RM; Pashapoor S; Sun J; Xu Z; Panthi B; Son JB; Guirguis MS; Patel MM; Whitman GJ; Moseley TW; Scoggins ME; White JB; Litton JK; Valero V; Hunt KK; Tripathy D; Yang W; Wei P; Yam C; Pagel MD; Rauch GM; Ma J
Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38083160
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
[TBL] [Abstract][Full Text] [Related]
20. Features from Computerized Texture Analysis of Breast Cancers at Pretreatment MR Imaging Are Associated with Response to Neoadjuvant Chemotherapy.
Chamming's F; Ueno Y; Ferré R; Kao E; Jannot AS; Chong J; Omeroglu A; Mesurolle B; Reinhold C; Gallix B
Radiology; 2018 Feb; 286(2):412-420. PubMed ID: 28980886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
